Roland B. Walter MD, PhD

Cancer Biology , epidemiology , antibodies , biomarker discovery , flow/FACS , drug development/application , personalized medicine , clinical trials , prognosis , treatments (intervention) , outcome (survival) , therapy


Dr. Walter's research is focused on human acute myeloid leukemia (AML). He is particularly interested in the delineation of the clonal origin of AML, the molecular and phenotypic characterization of AML stem and progenitor cells, and the interaction between AML cells and their environment. An overarching goal of these studies is the development of targeted treatments aimed to eradicate disease-relevant AML cells, with CD33-directed therapies being one important specific example. He is also involved in the early testing of novel drugs and innovative care approaches in patients with AML. And he participates in collaborative projects utilizing large datasets that aim to improve diagnostic and prognostic tools in AML or, together with epidemiologists, study risk factors for the development of this hematological malignancy.


Fred Hutch Clinical Research Associate Professor
University of Washington School of Medicine Hematology Associate Professor